企業プロフィール
Trevi Therapeutics 株価・ニュース・カタリスト
- ティッカー:
- TRVI
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
18.08 USD (+0.67%)
終値
最終更新: 2026年8月24日
1.92B USD
時価総額
株価変動の要因
As of Aug 24, 2026, TRVI closed up 0.67% at $18.08. No new same-company headline was identified in the current news window.
企業概要
事業概要
Trevi Therapeutics is a neuroscience and cough-related company focused on chronic cough and severe pruritus biology. Its programs aim to address symptom burdens with targeted therapies.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, Trevi sits in specialty biotechnology.
ビジネスモデルの特徴
The company depends on clinical validation, symptom-specific differentiation, and the ability to build a focused CNS/respiratory story.
バイオ業界での位置付け
Trevi is a high-catalyst specialty name where clinical data can quickly reshape the investment case.
今後のカタリスト
- Trevi’s catalysts are Haduvio and the chronic-cough / pruritus opportunities, with the next clinical step deciding whether the asset can become a real franchise. The stock is still driven by proof that the mechanism works in patients.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。